Decision Diagnostics Corp. (DECN)

Overview

Decision Diagnostics Corp. is a pioneering company that specializes in developing cutting-edge electronic medical record (EMR) technologies accessible through smartphones. Established in 2000 and based in Westlake Village, California, the company was initially known as InstaCare Corp. before rebranding to Decision Diagnostics Corp. in November 2011. It primarily focuses on offering innovative medical diagnostic solutions and e-health products that cater to both healthcare professionals and patients, particularly the chronically ill. Its commitment encompasses a wide spectrum, from the provision of diagnostic products, both prescription and non-prescription, fulfilment services for direct-to-patient diabetes programs, to the development of cell phone-centric health products and technologies. Additionally, Decision Diagnostics holds and manages an array of intellectual property, including patents and trademarks, and specializes in the manufacturing of specialty medical devices.

Products and Services

• GenUltimate! Glucose Test Strips: These Class II medical devices are designed for home use, enabling individuals to measure their glucose levels conveniently. Primarily aimed at diabetic patients, these test strips are an essential component of glucose monitoring.
• PetSure! Glucose Test Strips: Specially formulated for pets, these test strips work with the Zoetis AlphaTrak and AlphaTrak II glucometers, legacy meters renowned for their accuracy. They are designed for glucose testing in dogs and cats, making it easier for pet owners to manage their pets' diabetes.
• GenUltimate! 4Pets Glucose System: This proprietary system is comprised of the GenUltimate! 4Pets test strip and Avantage meter. It is developed for the glucose testing of dogs, cats, and horses, offering a comprehensive solution for pet diabetes management.
• GenUltimate! Sure and GenUltimate! Precis Test Strips: These test strips represent the latest in the company's line of glucose testing products. They promise enhanced accuracy and usability for better diabetes management.
• MD@Hand and Practice Probe: Part of Decision Diagnostics' EMR technologies, MD@Hand is an inpatient/outpatient management suite offering seamless medical record access and management for healthcare providers. Practice Probe complements this suite by providing a powerful data mining utility that extracts vital information from a physician’s practice management system, ensuring that practitioners have all the information they need at their fingertips.
• ResidenceWare: This is an innovative residential management system designed to improve the communication flow from commercial and residential real estate management companies to their tenants. It utilizes advanced networking software systems and applications to relay essential information efficiently.